AMRI names director of global project management

Michael D. Ironside, was named director of global project management by Albany Molecular Research Inc., the contract drug research and development company announced this morning. He will report to Steven Hagen, vice president of pharmaceutical development and manufacturing.

In this newly created role, Ironside will oversee all project management activities related to products moving through AMRI’s pharmaceutical services organization.

Ironside most recently served in a consultant role as president of Rondaxe Scientific Solutions. Before that, he was chief scientific officer at Biosignal, an emerging biotech company in Australia. Ironside also has eight years of experience at AMRI, joining the company in 1998 as a section head in chemical development and culminating in the oversight and leadership of AMRI’s chemical development and small scale cGMP (current Good Manufacturing Practice) unit.

Ironside holds a Ph.D in organic chemistry from Dundee University in Scotland and was a postdoctoral fellow at Sydney University in Australia.